ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620277 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620277; 2) Community: the network communities that were significantly associated with the response to NSC 620277; 3) Molecule: the relationships between components within communities and NSC 620277; 4) MDR: the compounds that were significantly associated with the NSC 620277.

NSC Compound Enrichment Correlation
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.00714731931708452 0.27203534
NSC 632877 Dicarbonyl[1-(phenylazo)naphthaline-2-olato(O1,N1)]- iridium(I) 0.00714731931708452 0.16404317
NSC 637578 N-[3-(2-Pyridyl)isoquinolin-1-yl]-2-pyridinecarboxamidine 0.00714731931708452 0.21028664
NSC 641691 Vicenistatin 0.00714731931708452 0.50978164
NSC 762555 Null 0.00714731931708452 -0.22603298
NSC 174121 Methotrexate Derivative 0.00744479268267742 0.45219881
NSC 271674 Carboxyphthalatoplatinum 0.00744479268267742 0.31340727
NSC 272346 1,7-Heptanediamine, N,N'-bis(2-methyl-7-nitro-4-quinolinyl)-, dihydrochloride 0.00744479268267742 0.29436646
NSC 608972 Null 0.00744479268267742 0.31273759
NSC 622926 Null 0.00744479268267744 -0.31203909
Total:139  Current:36    [First] [Prev] [Next] [Last]